SCHEMBL6208066

SCHEMBL6208066

[c]1c[nH]c(CCC2CCCCC2)n1

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
DAO P14920 3/20 0.38
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
HRH3 Q9Y5N1 3/20 0.35
HRH4 Q9H3N8 3/20 0.34
HTR3A P46098 1/20 0.34
BCHE P06276 1/20 0.34
CEL P19835 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7617332 1.00 DAO (0.38) DAOPOLBGAAHRH3HRH4
SCHEMBL7625880 0.91 HRH3 (0.34) DAOHRH3
SCHEMBL7617060 0.90 CEL (0.36) DAOHRH3HRH4CEL
SCHEMBL7615538 0.90 CEL (0.36) DAOHRH3HRH4CEL
SCHEMBL7620235 0.88 HRH3 (0.36) DAOHRH3CEL
SCHEMBL7625870 0.85 HRH3 (0.36) HRH3CEL
SCHEMBL7620211 0.82 HRH4 (0.43) DAOHRH3HRH4HTR3A
SCHEMBL7621930 0.82 HRH4 (0.43) DAOHRH3HRH4HTR3A
SCHEMBL7624059 0.81 HRH3 (0.37) HRH3
SCHEMBL8068830 0.74 TERT (0.42) DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1527068-A2 NOVEL ARYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2005-05-04 EP disclosed
WO-2004011402-A2 NOVEL ARYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-02-05 WO disclosed
EP-1232166-A2 SYNTHESIS OF 2'-DEOXY-L-NUCLEOSIDES Pharmasset Limited (US) 2002-08-21 EP disclosed
WO-2001034618-A2 SYNTHESIS OF 2'-DEOXY-L-NUCLEOSIDES PHARMASSET LIMITED (US) 2001-05-17 WO disclosed